Japanese drugmaker Shionogi said on Wednesday that it will acquire Torii Pharmaceutical , a subsidiary of Japan Tobacco , for ...

Focused on discount brands, it has allowed Japan Tobacco to benefit from the industry growth of the value and supervalue segments (now 44.5% share). The bottom line: We don't expect a major change ...

Shionogi has reached a JPY 151 billion ($1.04 billion) agreement to buy the pharmaceutical subsidiary of Japan Tobacco, Torii ...

Japan Tobacco Inc. ( OTCPK:JAPAY) Q1 2025 Results Conference Call May 7, 2025 6:00 AM ET Hiromasa Furukawa - Group Chief Financial Officer Dinesh Babu Thotakura - General Manager Nobuya Kato - JTI ...

JTI confirmed the deal, saying it was 'in line with our exploratory approach for reduced-risk products beyond heated tobacco ...

Japanese drugmaker Shionogi (TYO: 4507) is to scale up its pipeline and global ambitions with a deal worth more than $1 ...